Fig. 5From: The impact of COVID-19 on the prognosis of deep vein thrombosis following anticoagulation treatment: a two-year single-center retrospective cohort studyCumulative incidence of DVT aggravation or mortality among patients with different diseases in the PSM cohorts. (A) The cumulative incidence of DVT aggravation among patients with advanced lung cancer; (B) The all-cause mortality in patients with advanced lung cancer and DVT; (C) The cumulative incidence of postoperative DVT aggravation; (D) The cumulative incidence of DVT aggravation in patients with benign lung diseasesBack to article page